Anti-KIR combination treatments and methods
US10253095B2 · kind B2 · utility
4Cited by
11References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 15, 2011 |
| Grant date | Apr 9, 2019 |
| Priority date | — |
| Expiry date | Jul 15, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions comprising anti-KIR antibodies and one or more secondary anti-cancer agents or anti-viral agents and methods of using such combinations (as combination compositions or in separate administration protocols) in the treatment of cancers (e.g., lung cancer) or viral infection (e.g., HIV or HCV infection) are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.